© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 14, 1086-1087,
July 16, 2003
© 2003 Oxford University Press
CORRESPONDENCE |
Re: Insulin Resistance and Prostate Cancer Risk
Affiliations of authors: P. Stattin, Department of Urology and Andrology, Umeå University Hospital, Umeå, Sweden; R. Kaaks, Hormones and Cancer Group, International Agency for Research on Cancer, Lyon, France.
Correspondence to: Pär Stattin, M.D., Ph.D., Department of Urology, Umeå University Hospital, 901 85 Umeå, Sweden (e-mail: par.stattin@urologi.umu.se).
| The first 10% of the full text of this article appears below. |
In three papers from the same casecontrol series recruited from Shanghai, China, Hsing et al. (13) have reported statistically significant associations between prostate cancer risk and aspects of insulin resistance syndrome. First, they observed an increase in prostate cancer risk associated with abdominal obesity, measured by waist-to-hip ratio (odds
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Fan, T. Yanase, H. Morinaga, T. Okabe, M. Nomura, H. Daitoku, A. Fukamizu, S. Kato, R. Takayanagi, and H. Nawata Insulin-like Growth Factor 1/Insulin Signaling Activates Androgen Signaling through Direct Interactions of Foxo1 with Androgen Receptor J. Biol. Chem., March 9, 2007; 282(10): 7329 - 7338. [Abstract] [Full Text] [PDF] |
||||
